| Schedule of Net Loss Per Share, Basic and Diluted |
The following table sets forth the reconciliation of the numerator used to compute basic and diluted net loss per share of Class A common stock for the three and six months ended June 30, 2026 and 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(in thousands) |
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
Net loss |
$ |
(7,452 |
) |
|
$ |
(9,265 |
) |
|
$ |
(199,806 |
) |
|
$ |
(164,358 |
) |
Less: Net loss attributable to noncontrolling interests |
|
(2,030 |
) |
|
|
(1,714 |
) |
|
|
(55,763 |
) |
|
|
(49,579 |
) |
Net loss attributable to Definitive Healthcare Corp. |
$ |
(5,422 |
) |
|
$ |
(7,551 |
) |
|
$ |
(144,043 |
) |
|
|
(114,779 |
) |
The following table sets forth the computation of basic and diluted net loss per share of Class A common stock for the three and six months ended June 30, 2026 and 2025 (per share amounts unaudited).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(in thousands, except number of shares and per share amounts) |
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Basic and diluted net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss attributable to Definitive Healthcare Corp. |
$ |
(5,422 |
) |
|
$ |
(7,551 |
) |
|
$ |
(144,043 |
) |
|
$ |
(114,779 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares of Class A common stock outstanding |
|
105,810,516 |
|
|
|
106,815,740 |
|
|
|
105,245,928 |
|
|
|
109,782,640 |
|
Net loss per share, basic and diluted |
$ |
(0.05 |
) |
|
$ |
(0.07 |
) |
|
$ |
(1.37 |
) |
|
$ |
(1.05 |
) |
|
| Schedule of Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share |
The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the period presented because their effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, |
|
|
2026 |
|
|
2025 |
|
Definitive OpCo LLC Units (vested and unvested) |
|
38,094,660 |
|
|
|
38,395,357 |
|
Restricted Stock Units |
|
20,762,911 |
|
|
|
15,384,682 |
|
|